Because postmenopausal women on hormone therapy combined with GLP-1s often achieve significantly greater weight loss than those on GLP-1s alone, AI models could track symptoms alongside metabolic markers and help determine the optimal dosage of the GLP-1 to use in conjunction with hormone therapy, maximizing the benefit of both
Recently, it was also shown to behave as an antioxidant and an anti-inflammatory agent in various pathological conditions like hypertension, diabetes, and neurodegenerative diseases
We just spent Mardi Gras together
With FPA, you can prescribe independently (including controlled substances, with some caveats for Schedule II in the first year)
Jafari A, Dashti-Khavidaki S, Khalili H, Lessan-Pezeshki M